← Leaderboards
Latonya J Hickson
Mayo Clinic Rochester
$2,371,961
Attributed
$3,234,584
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $578.9K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,234,584 · 3
By mechanism
R01$1,725,246 · 1
K23$1,042,568 · 1
R03$466,770 · 1
Top collaborators
- Joy Wolfram3 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Paul D. Robbins$18,718,334
- Lilach O Lerman$25,904,470
- Nathan K Lebrasseur$21,937,905
- Alfonso Eirin$3,910,400
- Sundeep Khosla$91,221,003
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroCell AgingFutureCellsSenescenceKidney DiseasesDiabetic NephropathyClinical TrialsInflammatoryKidney FailureAnti-Inflammatory AgentsAgingAdipose TissueBloodAutologousPharmaceutical PreparationsPilot ProjectsPreconditioningNatural RegenerationParacrineIn VivoCell PhysiologyInnovationRegenerative
Grant awards (15)
Extracellular vesicle-based senotherapeutics for aging diabetic kidneydisease$567,364
R01 · FY2025 · AG · contact PI
Extracellular vesicle-based senotherapeutics for aging diabetic kidneydisease$578,941
R01 · FY2024 · AG · contact PI
Extracellular vesicle-based senotherapeutics for aging diabetic kidneydisease$578,941
R01 · FY2023 · AG · contact PI
Renal repair effects of senolytic preconditioned mesenchymal stromal cells in diabetic kidney disease$237,908
R03 · FY2021 · DK · contact PI
Mesenchymal stem cell senescence in diabetic nephropathy (K23 COVID Admin Supplement)$111,422
K23 · FY2021 · DK · contact PI
Mesenchymal stem cell senescence in diabetic nephropathy$52,513
K23 · FY2021 · DK · contact PI
Mesenchymal stem cell senescence in diabetic nephropathy$173,890
K23 · FY2020 · DK · contact PI
Renal repair effects of senolytic preconditioned mesenchymal stromal cells in diabetic kidney disease$111,272
R03 · FY2020 · DK · contact PI
Renal repair effects of senolytic preconditioned mesenchymal stromal cells in diabetic kidney disease$103,914
R03 · FY2020 · DK · contact PI
Renal repair effects of senolytic preconditioned mesenchymal stromal cells in diabetic kidney disease$13,675
R03 · FY2020 · DK · contact PI
Renal repair effects of senolytic preconditioned mesenchymal stromal PP #o20-111cells in diabetic kidney disease$1
R03 · FY2020 · DK · contact PI
Mesenchymal stem cell senescence in diabetic nephropathy$176,808
K23 · FY2019 · DK · contact PI
Mesenchymal stem cell senescence in diabetic nephropathy$182,383
K23 · FY2018 · DK · contact PI
Mesenchymal stem cell senescence in diabetic nephropathy$184,775
K23 · FY2017 · DK · contact PI
Mesenchymal stem cell senescence in diabetic nephropathy$160,777
K23 · FY2016 · DK · contact PI